- Home
- FLYX vs STRO Comparison
FLYX vs STRO Comparison
Compare FLYX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- STRO
- Stock Information
- Founded
- FLYX 2015
- STRO 2003
- Country
- FLYX United States
- STRO United States
- Employees
- FLYX N/A
- STRO N/A
- Industry
- FLYX Blank Checks
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLYX Finance
- STRO Health Care
- Exchange
- FLYX Nasdaq
- STRO Nasdaq
- Market Cap
- FLYX 79.8M
- STRO 94.9M
- IPO Year
- FLYX N/A
- STRO 2018
- Fundamental
- Price
- FLYX $3.30
- STRO $0.92
- Analyst Decision
- FLYX
- STRO Hold
- Analyst Count
- FLYX 0
- STRO 7
- Target Price
- FLYX N/A
- STRO $1.97
- AVG Volume (30 Days)
- FLYX 25.9K
- STRO 782.2K
- Earning Date
- FLYX 11-12-2025
- STRO 11-06-2025
- Dividend Yield
- FLYX N/A
- STRO N/A
- EPS Growth
- FLYX N/A
- STRO N/A
- EPS
- FLYX N/A
- STRO N/A
- Revenue
- FLYX $362,955,000.00
- STRO $105,646,000.00
- Revenue This Year
- FLYX $28.47
- STRO $65.48
- Revenue Next Year
- FLYX $22.44
- STRO N/A
- P/E Ratio
- FLYX N/A
- STRO N/A
- Revenue Growth
- FLYX 16.38
- STRO N/A
- 52 Week Low
- FLYX $1.90
- STRO $0.52
- 52 Week High
- FLYX $6.90
- STRO $3.01
- Technical
- Relative Strength Index (RSI)
- FLYX 46.14
- STRO 50.58
- Support Level
- FLYX $3.21
- STRO $0.83
- Resistance Level
- FLYX $3.49
- STRO $0.95
- Average True Range (ATR)
- FLYX 0.34
- STRO 0.07
- MACD
- FLYX 0.04
- STRO 0.00
- Stochastic Oscillator
- FLYX 45.45
- STRO 64.61
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.